المؤلفون: Davidson, AL, Dressel, U, Norris, S, Canson, DM, Glubb, DM, Fortuno, C, Hollway, GE, Parsons, MT, Vidgen, ME, Holmes, O, Koufariotis, LT, Lakis, V, Leonard, C, Wood, S, Xu, Q, Reed, AEM, Pickett, HA, Al-Shinnag, MK, Austin, RL, Burke, J, Cops, EJ, Nichols, CB, Goodwin, A, Harris, MT, Higgins, MJ, Ip, EL, Kiraly-Borri, C, Lau, C, Mansour, JL, Millward, MW, Monnik, MJ, Pachter, NS, Ragunathan, A, Susman, RD, Townshend, SL, Trainer, AH, Troth, SL, Tucker, KM, Wallis, MJ, Walsh, M, Williams, RA, Winship, IM, Newell, F, Tudini, E, Pearson, JV, Poplawski, NK, Mar Fan, HG, James, PA, Spurdle, AB, Waddell, N, Ward, RL

Relation: NHMRC/2000001; pii: 10.1186/s13073-023-01223-1; Davidson, A. L., Dressel, U., Norris, S., Canson, D. M., Glubb, D. M., Fortuno, C., Hollway, G. E., Parsons, M. T., Vidgen, M. E., Holmes, O., Koufariotis, L. T., Lakis, V., Leonard, C., Wood, S., Xu, Q., Reed, A. E. M., Pickett, H. A., Al-Shinnag, M. K., Austin, R. L. ,. Ward, R. L. (2023). The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study. Genome Medicine: medicine in the post-genomic era, 15 (1), https://doi.org/10.1186/s13073-023-01223-1.; http://hdl.handle.net/11343/339149

الاتاحة: http://hdl.handle.net/11343/339149